Purchase Order W9114F24P0060

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $151K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Nippon Gases Deutschland GMBH, doing business as Praxair Industriegase, a German manufacturer of industrial and medical gases. The $79,944.03 contract is for the delivery of medical gases, including oxygen, nitrogen, and helium, to U.S. military medical treatment facilities in Germany. This delivery order is executed against a larger $852,280.44 indefinite delivery contract (IDC) awarded to Praxair...
The Department of the Army Medical Command awarded a firm fixed price delivery order to Nippon Gases Deutschland GMBH, doing business as Praxair Industriegase, for the provision of medical gases to various facilities located in Germany. The $84,156.26 order was issued on October 1, 2022 under the awardee's single award indefinite delivery contract with the Army Medical Command, valued at up to $852,280 over five years, to supply essential medical gases for U.S. military treatment facilities...
This federal contract award is for the delivery of medical gases to the U.S. Army Medical Command (MEDCOM) in Germany. The prime contractor, Nippon Gases Deutschland GmbH (doing business as Praxair Industriegase), is a German manufacturer of industrial and medical gases. The contract is a firm fixed price delivery order worth $77,333.11, with a period of performance ending on September 30, 2024. Praxair Industriegase has previously held a five-year indefinite delivery contract (IDC) with...
This is a firm fixed price delivery order contract awarded to Nippon Gases Deutschland GMBH, doing business as Praxair Industriegase, for the delivery of medical gases to U.S. military facilities in Germany. The contract has a ceiling value of $26,381.51 and a period of performance through September 30, 2024. The contract was awarded by the Defense Health Agency, a defense agency responsible for healthcare services and logistics for the U.S. Armed Forces. The medical gases to be provided include...
The Department of the Army Medical Command awarded a $32,434.59 firm fixed price delivery order contract to Nippon Gases Deutschland GMBH, doing business as Praxair Industriegase, for deliveries of medical gases. The contract has a period of performance through September 30, 2021 and was awarded on October 1, 2020 without a set-aside designation. Under this contract, Praxair Industriegase will provide the Department of the Army Medical Command with deliveries of various medical gases to...
The Department of the Army Medical Command awarded a $26,499.14 firm fixed price delivery order contract to Nippon Gases Deutschland GMBH, doing business as Praxair Industriegase, for deliveries of medical gases with a completion date of September 30, 2022. The contract has no set-aside designation and will support the Army Medical Command's mission to provide essential medical gases to its healthcare facilities in Germany through September 2022. Nippon Gases Deutschland GMBH will deliver the...
The Department of the Army Medical Command awarded a $100,782.37 firm fixed price delivery order contract to Nippon Gases Deutschland GMBH, doing business as Praxair Industriegase, for deliveries of medical gases. The contract has a period of performance through September 30, 2022 and was awarded on October 1, 2021 without a set-aside designation. As the Army's medical logistics agency, the Medical Command supports the health care needs of soldiers worldwide; this contract will provide...
This is a federal contract award by the Defense Health Agency (DHA) to Strandmoellen GMBH & CO. KG, a German-based gas supplier, for the delivery of medical gases to U.S. military healthcare facilities in Germany and Belgium. The contract, valued at $149,426.10, is a firm-fixed-price purchase order with a performance period ending on September 30, 2025. The contract is for the supply of various medical gases, including oxygen, nitrogen, nitrous oxide, carbon dioxide, and medical air, to...
The Defense Health Agency awarded a Firm Fixed Price contract to Praxair Distribution Mid-Atlantic, LLC, a for-profit limited liability company that manufactures goods, for the procurement of medical gases such as oxygen, nitrogen, helium, xenon, and krypton. This $24,424.23 contract is a call against an existing Blanket Purchase Agreement (BPA) between Praxair and the Defense Health Agency, which has a total potential value of $6.5 million to provide medical gases to support the agency's...
This is a firm fixed price delivery order contract awarded by the Defense Health Agency (DHA) to Strandmoellen GMBH & CO. KG, a German gas supplier, to provide medical gases such as oxygen, nitrogen, nitrous oxide, and carbon dioxide to U.S. military treatment facilities in Germany. The contract has a ceiling value of $100,812.00 and a period of performance ending on September 30, 2016. This order is part of a larger indefinite delivery contract held by Strandmoellen with the DHA, valued...

This firm fixed-price purchase order was awarded by the U.S. Army Medical Command (MEDCOM) to Nippon Gases Deutschland GmbH, doing business as Praxair Industriegase, a German manufacturer of industrial and medical gases. The $150,577.58 contract is for the delivery of medical gases, including oxygen, nitrogen, and helium, to U.S. military medical treatment facilities in Europe over a one-year period ending September 30, 2025. This award is not associated with a set-aside program. Praxair Industriegase has an existing $852,280.44 indefinite delivery contract with MEDCOM to provide medical gases to Department of Defense healthcare facilities across Europe through September 2024.

Generated 1/29/25, 9:03 AM